KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares Issued
Ratios

Jazz Pharmaceuticals (JAZZ) Long-Term Debt Issuances: 2010-2017

Historic Long-Term Debt Issuances for Jazz Pharmaceuticals (JAZZ) over the last 2 years, with Dec 2017 value amounting to -$91,000.

  • Jazz Pharmaceuticals' Long-Term Debt Issuances rose 30.00% to -$91,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $994.2 million, marking a year-over-year increase of 0.20%. This contributed to the annual value of $980.8 million for FY2024, which is N/A change from last year.
  • As of Q4 2017, Jazz Pharmaceuticals' Long-Term Debt Issuances stood at -$91,000, which was up 30.00% from -$130,000 recorded in Q4 2016.
  • In the past 5 years, Jazz Pharmaceuticals' Long-Term Debt Issuances ranged from a high of $994.8 million in Q3 2016 and a low of -$2.0 million during Q3 2015.
  • Moreover, its 3-year median value for Long-Term Debt Issuances was -$110,500 (2016), whereas its average is $315.5 million.
  • As far as peak fluctuations go, Jazz Pharmaceuticals' Long-Term Debt Issuances tumbled by 100.37% in 2015, and later surged by 48,791.97% in 2016.
  • Jazz Pharmaceuticals' Long-Term Debt Issuances (Quarterly) stood at $553.4 million in 2013, then rose by 1.01% to -$981,000 in 2014, then soared by 67.58% to -$318,000 in 2015, then skyrocketed by 59.12% to -$130,000 in 2016, then skyrocketed by 30.00% to -$91,000 in 2017.
  • Its Long-Term Debt Issuances stands at -$91,000 for Q4 2017, versus -$130,000 for Q4 2016 and $994.8 million for Q3 2016.